0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Heart failure with preserved, mid‐range, and reduced ejection fraction across health care settings: an observational study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims

          This study aimed to assess the sex‐specific distribution of heart failure (HF) with preserved, mid‐range, and reduced ejection fraction across three health care settings.

          Methods and results

          In this descriptive observational study, we retrieved the distribution of HF types [with reduced ejection fraction (HFrEF), mid‐range ejection fraction (HFmrEF), and preserved ejection fraction (HFpEF)] for men and women between 65 and 79 years of age in three health care settings from a single country: (i) patients with screening‐detected HF in the high‐risk community (i.e. those with shortness of breath, frailty, diabetes mellitus, and chronic obstructive pulmonary disease) from four screening studies, (ii) patients with confirmed HF from primary care derived from a single observational study, and (iii) patients with confirmed HF from outpatient cardiology clinics participating in a registry. Among 1407 patients from the high‐risk community, 288 had screen‐detected HF (15% HFrEF, 12% HFmrEF, 74% HFpEF), and 51% of the screen‐detected HF patients were women. In both women (82%) and men (65%), HFpEF was the most prevalent HF type. In the routine general practice population (30 practices, 70 000 individuals), among the 160 confirmed HF cases, 35% had HFrEF, 23% HFmrEF, and 43% HFpEF, and in total, 43% were women. In women, HFpEF was the most prevalent HF type (52%), while in men, this was HFrEF (41%). In outpatient cardiology clinics ( n = 34), of the 4742 HF patients (66% HFrEF, 15% HFmrEF, 20% HFpEF), 36% were women. In both women (56%) and men (71%), HFrEF was the most prevalent HF type.

          Conclusions

          Both HF types and sex distribution vary considerably in HF patients of 65–79 years of age among health care settings. From the high‐risk community through to general practice to the cardiology outpatient setting, there is a shift in HF type from HFpEF to HFrEF and a decrease in the proportion of HF patients that are women.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: not found
          • Article: not found

          2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Epidemiology of heart failure

              The heart failure syndrome has first been described as an emerging epidemic about 25 years ago. Today, because of a growing and ageing population, the total number of heart failure patients still continues to rise. However, the case mix of heart failure seems to be evolving. Incidence has stabilized and may even be decreasing in some populations, but alarming opposite trends have been observed in the relatively young, possibly related to an increase in obesity. In addition, a clear transition towards heart failure with a preserved ejection fraction has occurred. Although this transition is partially artificial, due to improved recognition of heart failure as a disorder affecting the entire left ventricular ejection fraction spectrum, links can be made with the growing burden of obesity‐related diseases and with the ageing of the population. Similarly, evidence suggests that the number of patients with heart failure may be on the rise in low‐income countries struggling under the double burden of communicable diseases and conditions associated with a Western‐type lifestyle. These findings, together with the observation that the mortality rate of heart failure is declining less rapidly than previously, indicate we have not reached the end of the epidemic yet. In this review, the evolving epidemiology of heart failure is put into perspective, to discern major trends and project future directions.
                Bookmark

                Author and article information

                Contributors
                a.r.deboer-9@umcutrecht.nl
                Journal
                ESC Heart Fail
                ESC Heart Fail
                10.1002/(ISSN)2055-5822
                EHF2
                ESC Heart Failure
                John Wiley and Sons Inc. (Hoboken )
                2055-5822
                09 December 2021
                February 2022
                : 9
                : 1 ( doiID: 10.1002/ehf2.v9.1 )
                : 363-372
                Affiliations
                [ 1 ] Julius Center for Health Sciences and Primary Care University Medical Center Utrecht, Utrecht University Heidelberglaan 100 Utrecht 3584 CX The Netherlands
                [ 2 ] Dutch Heart Foundation The Hague The Netherlands
                [ 3 ] Department of Cardiology Erasmus MC University Medical Center Rotterdam The Netherlands
                [ 4 ] Amphia Academy Amphia The Netherlands
                [ 5 ] Department of Cardiology Maastricht University Medical Center Maastricht The Netherlands
                [ 6 ] Department of Cardiology Hospital Group Twente Almelo and Hengelo The Netherlands
                [ 7 ] Experimental Cardiology, Division Heart & Lung Disease University Medical Center Utrecht, Utrecht University Utrecht The Netherlands
                Author notes
                [*] [* ] Correspondence to: Annemarijn R. de Boer, MD, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Fax: 088 75 68099. Email: a.r.deboer-9@ 123456umcutrecht.nl

                Author information
                https://orcid.org/0000-0003-4200-0917
                https://orcid.org/0000-0002-5522-9318
                https://orcid.org/0000-0002-4356-8566
                https://orcid.org/0000-0002-3339-1955
                https://orcid.org/0000-0003-2871-9810
                https://orcid.org/0000-0001-9762-014X
                https://orcid.org/0000-0002-5052-7332
                Article
                EHF213742 ESCHF-21-00236
                10.1002/ehf2.13742
                8787985
                34889076
                8590c1a5-380e-4cf8-a8fb-be59601cff1a
                © 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

                History
                : 09 June 2021
                : 12 November 2021
                Page count
                Figures: 1, Tables: 3, Pages: 10, Words: 3561
                Funding
                Funded by: Hartstichting , doi 10.13039/501100002996;
                Award ID: Facts and Figures
                Award ID: CVON2014‐11 RECONNECT
                Award ID: CVON 2013T084 Queen of Hearts
                Funded by: Servier , doi 10.13039/501100011725;
                Funded by: ZonMw , doi 10.13039/501100001826;
                Award ID: 849100003
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                February 2022
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.0 mode:remove_FC converted:25.01.2022

                heart failure,sex differences,hfref,hfmref,screening
                heart failure, sex differences, hfref, hfmref, screening

                Comments

                Comment on this article